Dr. Angela Cheung
Dr. Angela Cheung is the Founding Director of University Health Network Osteoporosis Program, the Founding Director of Centre of Excellence in Skeletal Health Assessment (CESHA), a Senior Scientist at Toronto General Research Institute, and Professor of Medicine at the University of Toronto. She is currently holding a Tier 1 Canada Research Chair in Musculoskeletal and Postmenopausal Health. She is the past chair for Osteoporosis Canada Scientific Advisory Council, and an elected member of the International Osteoporosis Foundation Council of Scientific Advisors. She obtained her M.D. degree from Johns Hopkins University School of Medicine in 1988, and her Ph.D. degree from Harvard University in 1997. She has been in clinical practice for more than 25 years, and specializes in osteoporosis and postmenopausal health. She has received many honors and awards throughout her medical career for her excellence in clinical work, research and education, including the CIHR mid-career and senior scientist awards, the Canadian Society of Internal Medicine Dr. David Sackett Senior Investigator Award, the Osteoporosis Canada Lindy Fraser Memorial Award, the Ontario Premier’s Research Excellence Award, Ontario Ministry of Health and Long Term Care Health Services Research Scientist Award, University of Toronto Eudenie Stuart Award for best mentorship, and UHN Department of Medicine Award for Excellence in Clinical Teaching. She has been a member of the International Society of Clinical Densitometry (ISCD) since 1998 and has served on the Publication Committee. She is the current chair of the Canadian ISCD Panel.
Dr. Rick Adachi
Dr. Rick Adachi is a Professor of Medicine at McMaster University. He is the inaugural holder of the Alliance for Better Bone Health Chair in Rheumatology. He is a graduate of McMaster University and received his fellowship in Internal Medicine and in Rheumatology. Dr. Adachi received the First Annual Phillip Rosen Award when he completed his training in Rheumatology. He was awarded the Lindy Fraser Award by Osteoporosis Canada. In 2006, he received the North American Menopause Society award for Innovation in Osteoporosis Research. In 2012, he was received the Queen Elizabeth II Diamond Jubilee Medal for his work in osteoporosis. In 2014 he was received the Olof Johnell Science Award for his contributions to the field of osteoporosis. Dr. Adachi is a past president and member of the Scientific Advisory Council of Osteoporosis Canada. He is a member of the Council of Scientific Advisors of the International Osteoporosis Foundation and Board of Directors. He has participated in clinical trials and epidemiologic research examining a wide variety of risk factors and therapies in osteoporosis. Dr. Adachi has participated in the development of guidelines for osteoporosis.
Dr. Alan Bell
Dr. Bell is a family physician and clinical researcher in Toronto, Canada. He is Assistant Professor in the Department of Family and Community Medicine, University of Toronto and on the active staff of the Humber River Regional Hospital. He is a recipient of the Canadian College of Family Physicians Award of Excellence. Dr. Bell has been Past Chair and Current Primary Panel for the Canadian Cardiovascular Society Antiplatelet Guideline Committee. Dr. Bell is the only primary care physician to ever chair a CCS guideline committee. He has been a member of the Primary Panel for the Canadian Cardiovascular Society Atrial Fibrillation Guideline Committee, the Executive Council for Thrombosis Canada, a member of the American Society of Bone and Mineral Research, the Canadian Stroke Network Professional Development Committee, and a Peer Reviewer for the Canadian Medical Association Journal.
Dr. Neil Binkley
Dr. Neil Binkley earned his medical degree from the University of Wisconsin Medical School (Madison, WI, USA) and subsequently received his training in Internal Medicine at the Marshfield Clinic. After several years in private practice, he returned to the University of Wisconsin and completed a Geriatrics fellowship. He is a Professor in the Divisions of Geriatrics and Endocrinology at the University of Wisconsin where he is also Director of the UW Osteoporosis Clinical Center and Research Program and Associate Director of the UW Institute on Aging. He is past President of the International Society for Clinical Densitometry. His current research involves evaluation of approaches to optimize assessment of vitamin D status, exploring racial/ethnic differences in response to vitamin D supplementation, evaluation of functional assessment in older adults and the importance of sarcopenia in fracture risk.
Dr. Roberta Bondar
The world’s first neurologist in space, Dr. Roberta Bondar is globally recognized for her pioneering contribution to space medicine research. Aboard the Discovery mission STS-42, the First International Microgravity Laboratory in 1992, she conducted over 40 investigations from 13 countries. For more than 12 years at NASA, Dr. Bondar headed an international research team, continuing to find new connections between astronauts recovering from the microgravity of space and neurological illnesses here on Earth. Her techniques have been used in clinical studies at the B. I. Deaconess Medical Center, a teaching hospital of Harvard Medical School and at the University of New Mexico. Dr. Bondar served two terms as Chancellor of Trent University in Peterborough, Ontario.
Dr. Bondar has also earned a reputation as a leading speaker and consultant within the medical and scientific communities, and in the field of corporate social responsibility and care for the Earth's environment. She co-founded The Roberta Bondar Foundation, a not for profit charitable organization, to reconnect us to the natural environment.
Dr. Bondar holds the following degrees: BSc University of Guelph, MSc University of Western Ontario, PhD University of Toronto, MD McMaster University, Board Certification Neurology, Royal College of Physicians and Surgeons of Canada with subspecialty in Neuro-ophthalmology, Tuft’s New England Medical Ctr, Boston MA. She is a graduate of and an examiner for The Institute of Corporate Directors.
Among awards and honours, Dr. Bondar has been recognized with the NASA Space Medal, inducted into the Canadian Medical Hall of Fame and into the International Women’s Forum Hall of Fame for her pioneering research in space medicine. She is a recipient of the Order of Canada and the Order of Ontario. In 2011, Dr. Bondar received her own star on Canada’s Walk of Fame.
www.robertabondar.com www.therobertabondarfoundation.org
Dr. Jacques Brown
Jacques P. Brown is a rheumatologist and Canadian authority in metabolic bone diseases. He is a clinical professor at the Faculty of Medicine, Université Laval and a clinical researcher at the CHU de Québec Research Centre – Université Laval. He is a Director for the Canadian Multicentre Osteoporosis Study and the Principal Investigator of the Recognizing Osteoporosis and its Consequences in Quebec Programme. Dr. Brown twice received the John B Johnson Award from The Paget Foundation for his outstanding contribution to Paget’s disease of bone research and was awarded the Lindy Fraser Memorial Award from Osteoporosis Canada for his leadership and dedication to the “2002 Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada”.
In 2009, he was decorated as a Knight of the Ordre national du Québec, the highest distinction awarded by the Quebec government.
Dr. Hance Clarke
Dr. Hance Clarke is the Director of Pain Services and the Medical Director of the Pain Research Unit at the Toronto General Hospital. After his medical doctor (MD) and anesthesia subspecialty training in Toronto he received his PhD from the Institute of Medical Sciences at the University of Toronto and is a member of the Royal College Clinician Scientist Program. Dr. Clarke was awarded the 2016 Early Career Award from the Canadian Pain Society and recognized nationally for his research productivity as well as improvements to patient care such as the development of his novel Transitional Pain Program. He is a key opinion leader with respect to pain practices, opioid use/misuse policies, and the pending legalization/medicalization of cannabis.
Anita Colquhoun
Anita Colquhoun is the charge technologist in the Centre for Osteoporosis & Bone Health at the Women’s College Hospital in Toronto. Anita is a Nuclear Medical Technologist specialized in Bone Mineral Density (BMD). She has been working in the field of BMD since the early 1990s. Anita is an active member ISCD Technologist Faculty since 2000. She has served 2 terms on the Governing Board of the ISCD and is currently serving her third term as the Executive Secretary to the Board. Anita Chaired the Annual Meeting Committee for the past 4 years and serves on several other committees within the ISCD. She has participated in a variety of research studies and has co-authored abstracts and papers. Anita has also co-written an on-line beginner BMD course as well as developed a competency profile and best practise in BMD for the Ontario Association of Medical Radiation Sciences.
Dr. Christine Derzko
Dr. Christine Derzko completed undergraduate medicine and specialty training in Obstetrics and Gynecology at the University of Toronto. Her initial subspecialty training in reproductive endocrinology began in Toronto and was followed by additional post fellowship studies in reproductive & pediatric endocrinology at UCLA. She returned to St Michael’s Hospital and the University of Toronto where she is an Associate Professor, Department of Obstetrics and Gynecology with a cross appointment to the Department of Medicine, Division of Endocrinology. Dr Derzko is a long time member of the U of Toronto Bone and Mineral Group and of the Scientific Advisory Council of Osteoporosis Canada. At St Michael’s Hospital she is actively involved in osteoporosis research and teaching and is attending staff in the Osteoporosis/Metabolic Bone Clinic, She is currently Vice President of SIGMA-CMS the Canadian Menopause Society. Her major clinical and research interests include menopause, hormone therapy, osteoporosis, premature ovarian failure, sexuality and management of the gynecological consequence of cancer therapy.
Dr. Lora Giangregorio
Dr. Lora Giangregorio is an Associate Professor in the Department of Kinesiology at the University of Waterloo, and an affiliated scientist with University Health Network, the Geriatric Education and Research in Aging Sciences Centre, and the Schlegel-UW Research Institute for Aging. She leads the Bone Health and Exercise Science Laboratory (BonES lab), and her research aims to reduce the burden of osteoporotic fractures, with a focus on safe and effective physical activity. She is a member of the Scientific Advisory Council for Osteoporosis Canada, and she contributed to the development of Osteoporosis Canada’s Bone FitTM exercise training program.
Dr. Heather Frame
Dr. Heather Frame is a Family Physician in Winnipeg Manitoba. She practices family medicine at Assiniboine Clinic and in the Mature Women’s Center Osteoporosis Clinic at Victoria Hospital. She sits on the Manitoba Bone Density Committee. She has been associated with Scientific Advisory Council since 2005 and is the current ViceChair of the Board of Directors of Osteoporosis Canada.
Dr. Famida Jiwa
Dr. Famida Jiwa is the President and CEO of Osteoporosis Canada, and has been with the organization since 2006. Prior to joining Osteoporosis Canada, Dr. Jiwa was the former Provincial Osteoporosis Co-ordinator, employed by the Ontario Ministry of Health and Long Term Care and charged with rolling out all aspects of the $5 million annual Ontario Osteoporosis Strategy. Prior to this and after leaving her private practice in Orlando, Florida, Dr. Jiwa was a Program Consultant for the Acute Services Division of the Ministry of Health, where she played a significant role in project planning, implementation and evaluation of a number of provincial health initiatives, including chronic kidney disease, asthma and age-related macular degeneration. In 2014, Dr. Jiwa was re-elected chair of the Patient Societies Subcommittee of the Committee of National Societies (CNS) of the International Osteoporosis Foundation (IOF) for for a 4th term of two years. Activities of these societies include lobbying for better prevention, promoting early diagnosis for those at high risk for osteoporosis and empowering the patient through support groups and independent information about treatment options.
She holds a Masters Degree in Health Administration from the Department of Health Policy, Management and Evaluation from the University of Toronto, a Doctorate of Chiropractic from the Canadian Memorial Chiropractic College in Toronto, as well as an Honours Bachelor of Science, Genetics and Psychology from the University of Toronto. She was the recipient of the 2006 Robert Duff Baron Scholarship for academic excellence and leadership in public and community health. Dr. Jiwa has also attained the designation of Certified Health Executive from the Canadian College of Health Service Executives.
Dr. Stephanie Kaiser
Dr. Stephanie M. Kaiser is the Head of the Division of Endocrinology and Metabolism at the Queen Elizabeth II Health Sciences Centre and Professor of Medicine at Dalhousie University in Halifax, Nova Scotia. Dr. Kaiser is a member of the Osteoporosis Canada Scientific Advisory Council and is on the Executive Committee as well as co-Chair of the Knowledge Translation committee. She was a co-author of the Osteoporosis Guidelines in 2002 and again in 2010, and she is a co-investigator for the Canadian Multicentre Osteoporosis Study. Dr. Kaiser has over 50 publications in peer-reviewed journals. Dr. Kaiser is currently Past President of the Canadian Society of Endocrinology and Metabolism (CSEM). She was the recipient of the CSEM 2009 Educator of the Year Award and was awarded the Queen Elizabeth II Diamond Jubilee Medal for her work in osteoporosis in 2012.
Dr. David Kendler
Dr. David L Kendler graduated from the MD program at the University of Toronto in 1977. After completing a rotating internship in Toronto, he practiced for several years in Canada, Botswana, and New Zealand. He returned to Internal Medicine training in 1983 in Christchurch, New Zealand and in 1984 joined the Internal Medicine program in Halifax, Canada. In 1985 he moved to Vancouver to complete Internal Medicine and Endocrinology training at the University of British Columbia. After a 2-year thyroid immunology Fellowship in New York, he returned to the University of British Columbia Faculty of Medicine where he is now a Professor of Medicine in Endocrinology. He has led osteoporosis programs at Children and Women’s Hospital and St. Paul’s Hospital. He is the director of Prohealth Clinical Research, a major North American centre for clinical trials in the area of osteoporosis. He serves on the Scientific Advisory Council of Osteoporosis Canada and Chairs the Western Osteoporosis Alliance. He is a Past-President of the International Society for Clinical Densitometry. He is a member of the Committee of Scientific Advisors of the International Osteoporosis Foundation and is co-Chair of the Western Osteoporosis Alliance. He has been awarded the John Bilezekian ISCD Global Leadership Award. He has served on the Board of Directors of the Canadian Menopause Society. He has published over 120 peer-reviewed papers on osteoporosis therapies, osteoporosis risk assessment, and autoimmune thyroid disease.
Dr. Aliya Khan
Dr. Aliya Khan is a Professor of Clinical Medicine, Divisions of Endocrinology and Metabolism and Geriatrics at McMaster University and Director of the Calcium Disorders Clinic at McMaster University. She graduated from the University of Ottawa Medical School with Honors and completed postgraduate training at the University of Toronto. She has published over 150 scientific papers on osteoporosis and parathyroid disease as well as numerous book chapters and is the Editor of the Handbook of Parathyroid Diseases. Dr. Khan has been recognized by national and international awards including the International Clinician Instructor of the Year 2011 award by the International Society of Clinical Densitometry.The Queen’s Diamond Jubilee Medal for 2012 for excellence in clinical care, research and teaching as well as the International Hypoparathyroidism Award for 2014.
Dr. Sandra Kim
Dr. Sandra Kim is an Assistant Professor of Medicine in the Division of Endocrinology and Clinician Teacher at the University of Toronto. She is the Director of the Osteoporosis Program at Women’s College Hospital and the Vice-Chair of the Scientific Advisory Council for Osteoporosis Canada. She is involved with the Ontario Osteoporosis Strategy with the Ministry of Health in leading Osteoporosis Care Outreach and Inter-Professional Education delivered through the Ontario Telemedicine Network. In addition, she is involved in improving the quality and appropriateness of bone density testing in Ontario. Dr. Kim is the recipient of several education awards and has an interest in quality improvement and patient safety strategies.
Gordon Ko
Dr. Gordon D. Ko is Medical Director, at the Physiatry Interventional Pain clinics at Sunnybrook Health Sciences Centre, and the Canadian Centre for Integrative Medicine (CCIM, Markham). He is Adjunct Lecturer, Department of Medicine, University of Toronto and former Senior University Associate Professor. His expertise includes EMG-guided Botulinum Toxin-A injections for the treatment of pain, cervical dystonia, migraine and spasticity; and Ultrasound-guided viscosupplements and Platelet-Rich Plasma (PRP) injections. This also includes developing “Regenerative Medicine” and researching PRP-Stem Cell (adipose tissue) injections for moderate knee osteoarthritis(OA). At the CCIM, he leads an interdisciplinary team that includes chiropractors, manipulative physiotherapists, osteopaths, acupuncturists (TCM and IMS), dietician and naturopath specialized in Functional Medicine—with a focus on identifying and treating the root causes of chronic pain and disease. Dr. Ko has been using Botox since the early 1990’s and has trained over 100 physicians in injection techniques. He has taught extensively on pharmacotherapies including medical cannabinoids for neuropathic pain. He also was one of 11 medical professionals that established the 2012 Canadian guidelines for Fibromyalgia. After serving at the Mully Children’s Family orphanage in Kenya, he and his wife Dr. Annie Hum authored the handbook “The Blood, Bugs and Guts to Healing”. He also continues to serve as Vice President and founding director for the Canadian Society for Neurotoxins in Pain (training MDs on Botox for pain) and as Executive Director, Canadian Association of Orthopaedic Medicine (teaching prolotherapy-PRP injections).
Dr. William Leslie
Dr. William Leslie is Professor of Medicine and Radiology at the University of Manitoba with over 350 peer-reviewed publications. His research interests are in fracture risk assessment and osteoporosis testing. He is Past President of the International Society for Clinical Densitometry, Past Chair of the Osteoporosis Canada Scientific Advisory Council, co-led the “2010 Clinical Practice Guidelines in Osteoporosis”, and Director of the Manitoba Bone Density Program.
Dr. Monica Maly
Dr. Monica Maly completed her physiotherapy, Masters, and doctoral degrees in the School of Rehabilitation Therapy at Queen's. She completed a post-doctoral fellowship in Physical Therapy at the University of Toronto and the Arthritis Community Research & Evaluation Unit. She was the recipient of a CIHR New Investigator Award. Monica explores joint biomechanics during exercise to develop physical activity guidelines for adults with the most common forms of arthritis that are associated with aging. To achieve this goal, she integrates laboratory-based motion analyses to explore joint loading during exercise with advanced imaging techniques to examine joint tissues. Monica's work is funded by CIHR, NSERC, and CFI and she is an active contributor to the Ontario Physiotherapy Association. She is currently an Associate Professor at the University of Waterloo in the Kinesiology program.
Heather McDonald-Blumer
Dr. Suzanne Morin
Dr. Suzanne Morin graduated from the Faculty of Medicine at Université Laval de Québec. She did her Internal Medicine specialty training and obtained a Master’s in epidemiology and biostatistics from McGill University, where she is now Associate Professor in the Department of Medicine, member of the divisions of General Internal Medicine, Endocrinology and Clinical Epidemiology and scientist at the Research Institute of the McGill University Health Center. Dr Morin’s research program includes the evaluation of health-related outcomes of osteoporosis, and implementation of health system improvement programs for patients who have sustained fractures such as fracture liaison services, pain management and recovery. She also studies the epidemiology and pathogenesis of atypical femur fractures associated with long-term bisphosphonate use, and safety of calcium supplements on vascular health in postmenopausal women. She is a scholar from the Fondsde Recherche du Québec en Santé, and has received funding from the Canadian Institutes of Health Research and other peer-reviewed agencies. Since 2015, she chairs the Scientific Advisory Council of Osteoporosis Canada.
Dr. Kieran Murphy
Professor Kieran Murphy graduated in 1986 from the Royal College of Surgeons in Ireland. During his 6 years in medical school he spent time overseas developing primary health care projects with Tibetan refugees with whom he still maintains involvement. He initially pursued the surgical pathway with a primary fellowship and BSc in anatomy, became interested in medical innovation and moved to the US, was accepted into radiology residency at Albany Medical Center, completing residency and Neuroradiology fellowship at the University of Michigan, and interventional neuroradiology fellowship at University of Geneva. He was then recruited by Johns Hopkins University to lead the division of Interventional Neuroradiology from 1998 to 2008. During that time he filed 60 patents on new medical devices, pioneering new routes, techniques and approaches to complex spine and neurovascular and CSF pathologies. He has started 8 medical device companies, two in France, 2 in Canada and 4 in the US. He has authored over 145 peer reviewed publications, published several textbooks and mentored over 50 residents and fellows. He was recruited by University of Toronto in August 2008 to 2012 where he was Professor, Vice Chair and Deputy Chief of the University of Toronto Department of Medical Imaging. He has been heavily involved in developing a culture of innovation, incubation and entrepreneurial behaviour in the Techna faculty. His devices are used 60,000 times a year world wide. His current focus is on spine augmentation, radiofrequency ablation of bone mets, ozone in disk herniation, antioxidant use in radiation injury reduction, and global medical education through www.medlantis.com, which he founded in 2010. His hobbies include medical device development, historic airplanes, race car driving and taking things apart.
Dr. Lynn Nash
Dr. Lynn Nash is a Family Physician who has been practicing full spectrum Family Medicine in Ancaster, Ontario for 38 years. She is also an Associate Clinical Professor in the Department of Family Medicine, McMaster University. She is a Past President of the Ontario College of Family Physicians and has been involved in providing Continuing Medical Education to Family Physicians for most of her career with the last several years focussing on osteoporosis and falls prevention. She is also a member of the Scientific Advisory Council for Osteoporosis Canada.
Dr. Alexandra Papaioannou
Dr. Alexandra Papaioannou is a Professor of Medicine at McMaster University in the Division of Geriatric Medicine, and a Geriatric Medicine Specialist at Hamilton Health Sciences, St Peter’s Hospital. She is the Scientific Director of the Geriatric Education and Research in Aging Sciences (GERAS) Centre. Dr. Papaioannou holds a joint appointment in the Division of Rheumatology. She is an associate member in the Department of Clinical Epidemiology and Biostatistics, and Medical Sciences. She is past Director of the Division of Geriatric Medicine at McMaster University. Dr. Papaioannou is a Canadian Institutes of Health (CIHR) and Eli-Lilly Research Chair. She completed a Masters of Science (MSc), Health Research Methods at McMaster University. Dr. Papaioannou has served on a number of Ontario Ministry of Health and Long Term Care (MOH LTC) committees; including serving as the Co-Chair of the MOH LTC Osteoporosis Strategy for Ontario, a public health initiative to prevent and reduce the impact of osteoporosis, fractures and falls. She is the lead investigator for the Long-term Care Ontario Osteoporosis Strategy, Co-Director of the Hamilton Canadian Multi-Centre Osteoporosis Study (CaMos).
Dr. Linda Probyn
Dr. Linda Probyn is a Musculoskeletal Radiologist at Sunnybrook Health Sciences Centre, University of Toronto. She graduated from the Faculty of Medicine at Western University, completed her Residency training at McMaster University followed by a Musculoskeletal Imaging Fellowship at the University of Toronto where she is now an Associate Professor in the Department of Medical Imaging. Dr. Probyn is the past Program Director for the Diagnostic Radiology Residency program and is now the Vice-Chair of Education for the Department of Medical Imaging at the University of Toronto. Dr. Probyn has clinical and research interests in a broad range of musculoskeletal diseases with a particular focus on ultrasound, sports injuries, trauma, osteoporosis and arthritis. She also has a strong interest in teaching and education including the use of ultrasound simulation to train learners. She has published several scholarly projects and presents her work and teaches at many National and International conferences.
Dr. Raja Rampersaud
Dr. Raja Rampersaud is an Orthopaedic Spine Surgeon at Toronto Western Hospital, University Health Network, Associate Professor of Surgery at University of Toronto, Lead of the Provincial Inter-professional Spine Assessment and Education Clinics (ISAEC), Co-Chair of the Provincial Quality Based Pathway, Neck and Low Back Pain, and Advocacy Chair of the Canadian Spine Society. Dr. Raja Rampersaud’s national and internationally recognized research focuses on prognostics, comparative effectiveness as well as health services research aimed at improvements in the delivery of patient centered musculoskeletal and spine care. Through his advocacy, the Inter-professional Spine Assessment and Education Clinic (ISAEC) was developed and funded by the Province of Ontario’s Ministry of Health and Long-Term Care (MOHLTC). He also chairs the MOHLTC Quality Based Pathway for Neck and Low Back Pain, which aims to improve the quality care for all Ontarians suffering from spinal degeneration and arthritis.
Dr. Stephen Robinovitch
Dr. Stephen Robinovitch is a Professor at Simon Fraser University in Vancouver, Canada, with dual appointments in Biomedical Physiology and Kinesiology, and Engineering Science. He conducts research on the biomechanics of falls and fall-related injuries (especially hip fracture and head injury) in older adults. Using a unique falling lab at SFU, his team examines balance maintenance and recovery, and safe landing techniques in falls. They also conduct studies in long-term care sites in the Vancouver area, analyzing how “real-life” falls occur in older adults, captured through video networks and wearable sensors. In more applied efforts, they work on developing low-cost solutions (e.g., wearable hip protectors and compliant flooring) to prevent injuries in the event of a fall, and testing these interventions through randomized clinical trials. Dr. Robinovitch is also leading research studies to improve our understanding of the cause and prevention of concussions in ice hockey. Dr. Robinovitch received a B.A.Sc. in 1988 in Mechanical Engineering from the University of British Columbia, Vancouver, Canada, an M.Sc. in 1990 in Mechanical Engineering from MIT, and a Ph.D. in 1995 in Medical Engineering from MIT/ Harvard. From 1995-2000, he was an Assistant Professor In-Residence in Orthopaedics at the University of California, San Francisco. He has published 89 peer-reviewed journal articles, and has received numerous awards, including a Tier II Canada Research Chair in Injury Prevention and Mobility Biomechanics, a New Investigator Award from CIHR, and a Scholar Award from the Michael Smith Foundation for Health Research.
Dr. Laurence Anthony Rubin
Dr. Laurence Rubin is currently a Staff Rheumatologist and staff physician of the Metabolic Bone Clinic at St. Michael’s Hospital (SMH), and Professor of Medicine, University of Toronto. After graduating from the University of Ottawa in 1977 in Medicine (Magna Cum Laude), he completed specialty training (Internal Medicine and Rheumatology) in the U. of Toronto and Postgraduate studies at the National Institutes of Health, Bethesda, Maryland (1983-86). He joined the Division of Rheumatology at Sunnybrook Health Science Centre (1986-1992), moved to Women's College Hospital (Division Director of Rheumatology, Director of the Multidisciplinary Osteoporosis Program 1992-2000) and then Saint Michaels Hospital(2000-present). He is a member of the Metabolic Bone clinic at SMH, the Principal Investigator of the Early Arthritis Clinic, and coordinates a multidisciplinary OA program. He has been the director and attending rheumatologist (quarterly visits) of the Timmins and District Hospital Arthritis Program for almost thirty years.
He has received Clinical) the Sanofi Winthrop Canadian Rheumatism Association Young Investigator's Award (1992), and peer reviewed grants from the Arthritis Society, the Medical Research Council, Heart and Stroke Foundation, the Leukemia Research Fund, the Physicians' Services Incorporated Foundation, the Dairy Farmers and the Natural Science & Engineering Research Council. He has published over 75 peer reviewed papers and reviews.
At the NIH, he developed and patented a novel test for immune activation - the Soluble IL-2 receptor ELISA, which was licensed and used worldwide for the past 30 years.
Dr. Rubin's main research interests are in hereditary (genetic) factors in autoimmune/inflammatory disorders, metabolic bone disease and osteoporosis.
Dr. Marla Shapiro
Dr. Marla Shapiro completed medical school at McGill University and trained at the University of Toronto for her Masters of Health Science. She concluded her specialty training in Community Medicine, receiving her Fellowship in Preventive Medicine and Public Health from the Royal College of Physicians and Surgeons of Canada, and is currently a Professor in the Department of Family and Community Medicine at the University of Toronto. In addition to her weekly appearances on Canada AM, Dr. Shapiro is seen on CTV News Channel and is the medical consultant on CTV’s National News. She was the host of Balance: Television for Living Well and Dr. Marla and Friends, and writes a weekly blog for CTV. She is the founding editor of Parents Canada, and is also the author of the bestselling book, Life in the Balance: My Journey with Breast Cancer. Dr. Shapiro is a member of several advisory boards, including the Research Canada and the Board of Trustees of the North American Menopause Society where she is the incoming President. She received an Award of Excellence from the College of Family Physicians of Canada, and was awarded the Excellence in Creative Professional Activity by the University of Toronto. She is also the winner of the 2010 May Cohen Award, the 2010 Peter R. Newman Humanitarian Award was honored as a Woman of Action by the Israeli Cancer Research Foundation. In 2015, Dr. Shapiro was named to the Order of Canada, and was also chosen in the top 10 of the 50 most powerful doctors in Canada by the Medical Post.
Dr. Louis-Georges Ste-Marie
Dr. Louis-Georges Ste-Marie is an endocrinologist graduated from the Université de Montréal in 1980. Following his residency in endocrinology at Hôpital Saint-Luc in Montréal, Dr. Ste-Marie completed a Medical Research Council Fellowship in the endocrinology of calcium metabolism at the Massachusetts General Hospital of Boston. He went then for two additional years of research fellowship at the INSERM Unit of “Laboratoire d’histodynamique osseuse” in Lyon. At present time, Dr. Ste-Marie is Clinical Professor of Medicine at Université de Montréal. He is the Director of the Metabolic Bone Diseases Clinic and the Director of the Bone Histomorphometry Laboratory at the CHUM. His research interests have been in the areas of metabolic bone diseases including animal models of osteoporosis, skeletal metastasis and rickets. He has held a number of grants from provincial and national agencies for basic research. He has been a co-investigator in major international clinical trials of osteoporosis therapies. He has authored or co-authored more than 80 per-reviewed papers and six book chapters.
Dr. Wendy Ward
Dr. Wendy Ward is a Professor in the Faculty of Applied Health Sciences at Brock University where she holds a Canada Research Chair in Bone and Muscle Development. Wendy’s research program, funded by major government granting agencies, studies how foods and food components can set us on a better trajectory for bone health throughout the lifespan. The goal of her research program is to develop dietary strategies that help protect against fragility fracture and osteoporosis. These strategies include novel foods and food components such as soy and its isoflavones; flaxseed and its omega-3 fatty acid; fish oil; and flavonoids in tea. She has published many peer-reviewed articles, invited reviews and books chapters on nutrition and women’s health issues, including herbal and nutritional supplements. Wendy is a member of the Scientific Advisory Council of Osteoporosis Canada. She is actively involved in continuing education for health professionals and community groups on topics about nutrition and health.